Monday, 19 October 2026European Markets

GRIEG SEAFOOD Stock Went Up By Over 10% So Far Today

Loading stream...

(VIANEWS) - Shares of GRIEG SEAFOOD (Oslo Børs Benchmark Index_GI: GSF.OL) jumped by a staggering 10.52% to kr90.90 at 14:37 EST on Thursday, following the last session's downward trend. Oslo Børs Benchmark Index_GI is rising 0.82% to kr1,231.28, following the last session's downward trend. This seems, up to now, a somewhat positive trend exchanging session today.

GRIEG SEAFOOD's last close was kr82.25, 47.34% under its 52-week high of kr156.20.

About GRIEG SEAFOOD

Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the production and sale of Atlantic salmon. The company was founded in 1884 and is headquartered in Bergen, Norway. Grieg Seafood ASA operates as a subsidiary of Grieg Aqua AS.

Earnings Per Share

As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr7.29.

PE Ratio

GRIEG SEAFOOD has a trailing twelve months price to earnings ratio of 12.47. Meaning, the purchaser of the share is investing kr12.47 for every norwegian krone of annual earnings.

More news about GRIEG SEAFOOD (GSF.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com